OSCAR HEALTH INC - CLASS A (OSCR) Stock Analyst Ratings
USA - NYSE:OSCR - US6877931096 - Common Stock
18 USD
-0.09 (-0.5%)
18.12 USD
+0.12 (+0.67%)
ChartMill assigns a Buy % Consensus number of 49% to OSCR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 13.44. This target is -25.33% below the current price.
OSCR was analyzed by 15 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about OSCR.
In the previous month the buy percentage consensus was at a similar level.
OSCR was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-14 | Goldman Sachs | Initiate | Neutral |
| 2025-10-07 | Wells Fargo | Maintains | Underweight -> Underweight |
| 2025-08-14 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-07-25 | Baird | Downgrade | Outperform -> Neutral |
| 2025-07-23 | Barclays | Maintains | Underweight -> Underweight |
| 2025-07-15 | UBS | Downgrade | Neutral -> Sell |
| 2025-07-11 | Wells Fargo | Downgrade | Equal-Weight -> Underweight |
| 2025-07-02 | Barclays | Initiate | Underweight |
| 2025-06-09 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-03-13 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2024-12-10 | Jefferies | Initiate | Underperform |
| 2024-11-06 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2024-10-07 | UBS | Initiate | Neutral |
| 2024-09-10 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-08-08 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-07-10 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-06-26 | Piper Sandler | Initiate | Overweight |
| 2024-06-12 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-05-30 | Baird | Initiate | Outperform |
| 2024-05-30 | B of A Securities | Downgrade | Buy -> Neutral |
| 2024-05-20 | B of A Securities | Maintains | Buy -> Buy |
| 2024-05-09 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-05-09 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-03-22 | Raymond James | Initiate | Outperform |
| 2024-02-15 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-02-09 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-11-02 | B of A Securities | Upgrade | Neutral -> Buy |
| 2023-08-30 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-08-10 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-08-09 | Credit Suisse | Maintains | Outperform -> Outperform |
OSCAR HEALTH INC - CLASS A / OSCR FAQ
What is the price target for OSCR stock?
15 analysts have analysed OSCR and the average price target is 13.44 USD. This implies a price decrease of -25.33% is expected in the next year compared to the current price of 18.
What is the consensus rating for OSCAR HEALTH INC - CLASS A (OSCR) stock?
The consensus rating for OSCAR HEALTH INC - CLASS A (OSCR) is 49.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
How many analysts cover OSCAR HEALTH INC - CLASS A (OSCR) stock?
The number of analysts covering OSCAR HEALTH INC - CLASS A (OSCR) is 15.